- Report
- October 2024
- 184 Pages
Global
From €3181EUR$3,545USD£2,738GBP
€3534EUR$3,939USD£3,042GBP
- Report
- April 2025
- 283 Pages
Global
From €5249EUR$5,850USD£4,518GBP
- Report
- March 2025
- 146 Pages
Global
From €2691EUR$2,999USD£2,316GBP
- Report
- August 2024
- 178 Pages
Global
From €4038EUR$4,500USD£3,475GBP
- Report
- March 2025
- 182 Pages
Global
From €4038EUR$4,500USD£3,475GBP
- Report
- May 2024
- 100 Pages
Africa
From €1795EUR$2,000USD£1,545GBP
- Report
- May 2024
- 80 Pages
United States
From €1346EUR$1,500USD£1,158GBP
- Report
- February 2024
- 180 Pages
Global
From €4459EUR$4,969USD£3,837GBP
- Report
- May 2024
- 80 Pages
Argentina
From €1346EUR$1,500USD£1,158GBP
- Report
- May 2024
- 80 Pages
Brazil
From €1346EUR$1,500USD£1,158GBP
- Report
- May 2024
- 80 Pages
China
From €1346EUR$1,500USD£1,158GBP
- Report
- May 2024
- 80 Pages
France
From €1346EUR$1,500USD£1,158GBP
- Report
- May 2024
- 80 Pages
Germany
From €1346EUR$1,500USD£1,158GBP
- Report
- May 2024
- 80 Pages
India
From €1346EUR$1,500USD£1,158GBP
- Report
- May 2024
- 80 Pages
Ireland
From €1346EUR$1,500USD£1,158GBP
- Report
- May 2024
- 80 Pages
Japan
From €1346EUR$1,500USD£1,158GBP
- Report
- May 2024
- 80 Pages
Poland
From €1346EUR$1,500USD£1,158GBP
- Report
- May 2024
- 80 Pages
Russia
From €1346EUR$1,500USD£1,158GBP
- Report
- May 2024
- 80 Pages
Saudi Arabia
From €1346EUR$1,500USD£1,158GBP
- Report
- May 2024
- 80 Pages
South Korea
From €1346EUR$1,500USD£1,158GBP

Ethambutol is a drug used to treat respiratory diseases such as tuberculosis and Mycobacterium avium complex (MAC). It is an antibiotic that works by inhibiting the growth of bacteria in the lungs. It is usually prescribed in combination with other drugs to treat tuberculosis. Ethambutol is also used to prevent the spread of tuberculosis in people who have been exposed to the disease.
Ethambutol is available in both oral and injectable forms. It is usually taken once or twice daily, depending on the severity of the infection. Common side effects of ethambutol include nausea, vomiting, loss of appetite, and vision changes.
The ethambutol market is a growing segment of the respiratory drugs market. It is used to treat a variety of respiratory diseases, including tuberculosis and MAC. The increasing prevalence of tuberculosis and other respiratory diseases is driving the demand for ethambutol.
Some companies in the ethambutol market include Pfizer, GlaxoSmithKline, Merck, Sanofi, and Novartis. Show Less Read more